To Örebro University

oru.seÖrebro University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Nurse-Administered Gut-Directed Hypnotherapy for Irritable Bowel Syndrome: A Two-Year Follow-Up Study
Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Örebro University, School of Behavioural, Social and Legal Sciences. Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. (EMBRACE Lab; Center for Health and Medical Psychology (CHAMP))ORCID iD: 0009-0006-5516-8419
Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Show others and affiliations
2025 (English)In: United European Gastroenterology journal, ISSN 2050-6406, E-ISSN 2050-6414, Vol. 13, no 7, p. 1307-1317Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: Gut-directed hypnotherapy is effective for irritable bowel syndrome (IBS) and a few studies have reported long-lasting therapeutic effects following intervention. No previous studies have evaluated the long-term effects of nurse-administered hypnotherapy.

AIMS: We aimed to investigate the long-term effects of nurse-administered gut-directed hypnotherapy for IBS and identify factors associated with symptom improvement. Furthermore, we aimed to compare treatment effects between individual and group hypnotherapy.

METHODS: A 2-year follow-up study including 289 patients with IBS who had completed a 12-week hypnotherapy program (individually or in groups) was conducted. Data were collected at baseline, and at 6-month-, 1-year- and 2-year follow-ups. Irritable bowel syndrome and extracolonic symptom severity (IBS-SSS), gastrointestinal-specific anxiety (VSI), and anxiety and depressive symptoms (HADS) were assessed. Patients reporting a reduction ≥ 50 points (IBS-SSS) were classified as treatment responders.

RESULTS: The 2-year follow-up was completed by 207 patients. The proportion of responders at post-treatment was 64.3%, 62.8% at the 6-month follow-up, 64.7% at the 1-year follow-up, and 61.8% at the 2-year follow-up. The severity of IBS symptoms, extracolonic and psychological symptoms were all reduced post-treatment, and this effect lasted over the 2-year follow-up period (p < 0.001). Younger age, individual hypnotherapy, and severe irritable bowel syndrome symptoms at baseline predicted a better response to treatment (R2 = 0.16).

CONCLUSIONS: Nurse-administered gut-directed hypnotherapy is an effective treatment for IBS with long-lasting symptom improvements. Younger age, severe irritable bowel syndrome symptoms, and individual treatment might be important factors associated with effectiveness (ClinicalTrials.gov study protocol IDs: NCT06167018, NCT03432078).

TRIAL REGISTRATION: ClinicalTrials.gov study protocol IDs: NCT06167018, NCT03432078.

Place, publisher, year, edition, pages
John Wiley & Sons, 2025. Vol. 13, no 7, p. 1307-1317
Keywords [en]
Extracolonic symptom, gut‐brain axis, hypnotherapy, irritable bowel syndrome, nurse, psychological treatment
National Category
Gastroenterology and Hepatology
Identifiers
URN: urn:nbn:se:oru:diva-121563DOI: 10.1002/ueg2.70060ISI: 001506055000001PubMedID: 40491242Scopus ID: 2-s2.0-105007533954OAI: oai:DiVA.org:oru-121563DiVA, id: diva2:1968829
Funder
Region Västra Götaland, VGFOUREG 855971Region Västra Götaland, VGFOUREG 930214Swedish Research Council, 2018-02566Swedish Research Council, 2021-00947University of Gothenburg
Note

Funding Agencies:

This study was funded by the Healthcare Committee, Region Västra Götaland (Grants VGFOUREG 855971 and VGFOUREG 930214), the Swedish Research Council (Grants 2018-02566 and 2021-00947), the ALF- agreement (Grants ALFGBG-726561, ALFGBG-965173, ALFGBG-722331 and ALFGBG-983998) and the Faculty of Medicine, University of Gothenburg.

Available from: 2025-06-13 Created: 2025-06-13 Last updated: 2026-01-09Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Blomqvist-Storm, MichaelaTrindade, Ines

Search in DiVA

By author/editor
Blomqvist-Storm, MichaelaTrindade, Ines
By organisation
School of Behavioural, Social and Legal Sciences
In the same journal
United European Gastroenterology journal
Gastroenterology and Hepatology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 72 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf